Cargando…
Deciphering the Non-Coding RNA Landscape of Pediatric Acute Myeloid Leukemia
SIMPLE SUMMARY: Survival rates for children with acute myeloid leukemia have significantly improved in recent decades. Still, 20–30% will succumb to therapy-related toxicity and relapse. Research has shown that leukemic stem cells (LSCs) in particular are responsible for relapse. Therefore, the char...
Autores principales: | Vanhooren, Jolien, Van Camp, Laurens, Depreter, Barbara, de Jong, Martijn, Uyttebroeck, Anne, Van Damme, An, Dedeken, Laurence, Dresse, Marie-Françoise, van der Werff ten Bosch, Jutte, Hofmans, Mattias, Philippé, Jan, De Moerloose, Barbara, Lammens, Tim |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9100904/ https://www.ncbi.nlm.nih.gov/pubmed/35565228 http://dx.doi.org/10.3390/cancers14092098 |
Ejemplares similares
-
Clinical Significance of TARP Expression in Pediatric Acute Myeloid Leukemia
por: Depreter, Barbara, et al.
Publicado: (2020) -
CAR-T in the Treatment of Acute Myeloid Leukemia: Barriers and How to Overcome Them
por: Vanhooren, Jolien, et al.
Publicado: (2023) -
TARP as antigen in cancer immunotherapy
por: Vanhooren, Jolien, et al.
Publicado: (2021) -
TARP is an immunotherapeutic target in acute myeloid leukemia expressed in the leukemic stem cell compartment
por: Depreter, Barbara, et al.
Publicado: (2020) -
Long non-coding RNAs as novel therapeutic targets in juvenile myelomonocytic leukemia
por: Hofmans, Mattias, et al.
Publicado: (2021)